However, some lawsuits claim that Ozempic has caused people to suffer painful, disabling, and life-threatening gastrointestinal issues
had taken a glucagon-like peptide-1 (GLP-1) receptor agonist medications for the treatment of type 2 diabetes or, increasingly, for weight loss
It was approved by the FDA under the trade name Adlyxin in 2016 and launched in China in January 2018
So the center is aimed at tapping into patients who would like to utilize a medicine for weight loss or medical help for weight loss, Jolie Relle, a physician assistant with the Baton Rouge General Weight Loss Center, said
They help patients navigate side effects, optimize nutrition within reduced calorie intake, preserve muscle mass, and develop sustainable eating patterns that extend beyond medication use